Multiple brokerage houses have shared their latest technical and derivatives-based stock recommendations for June 30, highlighting opportunities across financials, banks and pharma sectors. According to reports from NDTV Profit, analysts recommendations largely focus on technically strong counters and clearly defined risk-reward setups, as markets continue to trade in a range-bound but stock-specific manner.
Piramal Finance has been recommended as a buy at ₹2,140 with a stop loss at ₹2,070 and a target of ₹2,240, indicating near-term upside potential on the charts. As reported by Angel One, Osho Krishan, Chief Manager – Technical and Derivative Research, has identified this financial stock as a technically strong opportunity for investors.
Meesho Ltd. has been recommended in the ₹192–194 range with a stop loss at ₹179 and an upside target of ₹225. According to IDBI Capital Markets and Securities, Sachin Janardan Sarvade, AVP – Derivatives, Retail Research, has advised accumulation in this e-commerce stock. Similarly, Honasa Consumer Ltd. has been recommended for accumulation between ₹440–446, with a stop loss at ₹414 and targeting ₹515. Both recommendations suggest significant upside potential from current market levels.
Bank of Maharashtra Ltd. has been recommended at ₹93.65 with a stop loss at ₹91 and a target price of ₹97. As reported by HDFC Securities, Vinay Rajani, Senior Technical Research Analyst, has identified this banking stock as a buying opportunity. The recommendation suggests potential for ₹5.45 upside from current levels.
Gland Pharma Ltd. has been suggested as a buy at ₹2,375 with a stop loss at ₹2,320 and a target of ₹2,500. According to HDFC Securities, Vinay Rajani has recommended this pharma stock, indicating potential for ₹125 upside from current market levels. The recommendation reflects positive technical analysis for the pharmaceutical sector.
